En
Da
Fr
De
Sv
Deal History
Services
Corporate Finance
Debt Advisory
Equity Research
Growth Equity Financing
IPO Strategy & Preparation
Industries
Business Services
Consumer/E-commerce
Digital Media / Internet
Industrial Technology
Life Sciences and Healthcare
Software / TMT
Insights
News
Newsletter
Research
About us
Company
Team
Offices
Globalscope
Career
Events
Contact
En
Da
Fr
De
Sv
Main menu button
Team
Deals
Contact
Equity Research
Team
Deals
Contact
News
All
Abera Bioscience
Adventure Box
Adverty
All for One Group
ALM Equity
Alzecure Pharma
Arctic Minerals
Biosergen
Candles Scandinavia
CellaVision
CSAM Health Group
DanCann Pharma
Ecoclime
Elicera Therapeutics
Frequentis
FRISQ
Future Gaming
GHP Specialty Care
H&D Wireless
Hanza
Hanza Holding AB
Herantis Pharma
InCoax
Kancera
Medclair Invest
Midsummer
Modus Therapeutics
Moninvent
NeoDynamics
Nischer Properties
Orion Corporation
Pharmiva
Raytelligence
Risk Intelligence
SBB i Norden
Sensec
Spotlight Group
Thinc Jetty
Ytrade Group
Zazz Energy
Zinzino
All
Company News
Corporate Finance
Equity Research
In Media
M&A Know-how
Macro and markets
Market Snapshots
22 Feb 2023
Carlsquare successfully advised SHD System-Haus-Dresden on its merger with Syserso Networks
Corporate Finance
22 Feb 2023
First impression Risk Intelligence, Q4 2022: Mixed outcome in comparison to our adjusted estimates
Equity Research
Risk Intelligence
22 Feb 2023
First impression ALM Equity, Q4 2022: Asset write downs impact results
Equity Research
ALM Equity
22 Feb 2023
Carlsquare weekly market letter: Better numbers push stocks lower, thanks to the Fed
Equity Research
20 Feb 2023
Carlsquare Equity Research Nordic Life Science sector update
Equity Research
Abera Bioscience
20 Feb 2023
Research Update Ecoclime Q4 2022: A very strong quarter for Evertherm
Equity Research
Ecoclime
17 Feb 2023
Update HANZA Q4 2022: Stars still aligned for expansion
Equity Research
Hanza
16 Feb 2023
First Impression Ecoclime Q4 2022: Better than expected revenue growth
Equity Research
Ecoclime
15 Feb 2023
Carlsquare successfully advised Keran Group in buying a majority stake in YS Energies Marine Developpement
Corporate Finance
15 Feb 2023
Carlsquare weekly market letter: Is SEK at a breakpoint and what does it imply for the stock market?
Equity Research
14 Feb 2023
Carlsquare successfully advised Chatchamp on the sale to trbo, a portfolio company of Nordwind Growth
Corporate Finance
14 Feb 2023
First impression HANZA, Q4 2022: No slowdown
Equity Research
Hanza
10 Feb 2023
Preview SBB, Q4 2022: Better valued after transactions
Equity Research
SBB i Norden
08 Feb 2023
Mrkt BUZZ Adverty: Above resistance after strong report
Equity Research
Adverty
08 Feb 2023
Carlsquare weekly market letter: MAAGT replaces the FANG companies
Equity Research
03 Feb 2023
Mrkt BUZZ Zinzino: Strong sales ahead of report
Equity Research
Zinzino
03 Feb 2023
Mrkt BUZZ Kancera: Fractalkine project towards new milestones
Equity Research
Kancera
02 Feb 2023
Research update Adverty, Q4 2022: Increased value after topped expectations
Equity Research
Adverty
01 Feb 2023
Research Update H&D Wireless Q4 2022: Increased likelihood of following major customers abroad
Equity Research
H&D Wireless
01 Feb 2023
First impressions Adverty, Q4 2022: Well above our expectations
Equity Research
Adverty
1
2
3
4
…
62